1.
J Clin Psychiatry
; 59(8): 431-2, 1998 Aug.
Article
in English
| MEDLINE
| ID: mdl-9721826
Subject(s)
Dizziness/chemically induced , Dizziness/drug therapy , Nausea/chemically induced , Nausea/drug therapy , Paroxetine/adverse effects , Phytotherapy , Selective Serotonin Reuptake Inhibitors/adverse effects , Substance Withdrawal Syndrome/drug therapy , Zingiberales/therapeutic use , Ataxia/chemically induced , Ataxia/drug therapy , Female , Humans , Substance Withdrawal Syndrome/etiology
2.
Am J Psychiatry
; 148(12): 1767, 1991 Dec.
Article
in English
| MEDLINE
| ID: mdl-1957960
3.
Hosp Community Psychiatry
; 37(5): 507-8, 1986 May.
Article
in English
| MEDLINE
| ID: mdl-3457756
4.
Am J Drug Alcohol Abuse
; 9(4): 413-30, 1982.
Article
in English
| MEDLINE
| ID: mdl-7188002
ABSTRACT
The Quantitative Inventory of Alcohol Disorders (QIAD) was developed to meet the need in the field of alcoholism treatment for an accurate, easily administered diagnostic tool which can measure the severity of alcoholism. This inventory is designed to be administered both on initial contact and as a follow-up after a given period of treatment. In addition to clearly differentiating alcoholic from nonalcoholic populations, the QIAD also proved to be both reliable and valid in comparison to other currently used severity (DBI) and diagnostic (MAST, DRC, NCA) scales.
